Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas: A Retrospective Observational

Marissa Barbaro1, Craig D Blinderman1, Fabio M Iwamoto1

  • 1From the Division of Neuro-Oncology (M.B., F.M.I., T.N.K., M.R.W., Y.O., L.E.D., K.A.E., A.B.L.), Department of Neurology, Herbert Irving Comprehensive Cancer Center (C.D.B., F.M.I., T.N.K., M.R.W., L.E.D., A.E.J.-G., A.B.L.), and Division of Hematology/Oncology (C.D.B.), Palliative Care Service Section, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital; Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola (M.B.), NYU Long Island School of Medicine, NYU Langone Health; Novartis AG (T.N.K.), East Hanover, NJ; Miami Cancer Institute (Y.O.), Baptist Health South Florida, FL; Department of Veterans Affairs (L.E.D.), James J. Peters Medical Center, Bronx (L.E.D.); and Montefiore Health System (K.A.E.), Bronx, NY.

Neurology
|November 19, 2021
PubMed

Insights

In patients with intracranial gliomas, clinical tumor progression was the most frequent cause of death. Most patients received comfort care, but 13.2% underwent resuscitation, highlighting the need for better end-of-life care discussions.

Area of Science:

  • Neuro-oncology
  • Palliative Care
  • Medical Ethics

Background:

  • Intracranial gliomas are aggressive brain tumors with significant end-of-life care challenges.
  • Understanding end-of-life patterns is crucial for improving patient and caregiver support.

Purpose of the Study:

  • To analyze the patterns of care and circumstances surrounding death in patients with intracranial gliomas.
  • To identify common causes of death, locations of death, and the use of comfort measures and resuscitation.

Main Methods:

  • Retrospective analysis of 152 patients with intracranial high-grade gliomas who died between January 2014 and February 2019.
  • Data collected included cause of death, place of death, and interventions such as comfort measures and resuscitation.

Main Results:

  • Clinical tumor progression (77.0%) was the leading cause of death, followed by infection (12.5%).
  • Hospice or comfort measures were used in 94.7% of patients; 48.0% died at home with hospice.
  • Resuscitative efforts were performed in 13.2% of patients.

Conclusions:

  • Clinical progression and infection are primary drivers of mortality in glioma patients.
  • While most patients receive comfort care, a notable percentage experience resuscitation, indicating a need for improved communication and planning.
  • Enhanced understanding of end-of-life trajectories can facilitate better physician-patient discussions and informed care planning.
Abstract

Related Concept Videos